Immunopathology of hepatitis B virus infection

International Reviews of Immunology

Volumn 27, Issue 6, 2008, Pages 427-446

  Tsai, Hsiu Ting ^a   Tsai, Tzu Hsin ^a   Lu, Tsong Ming ^a   Yang, Chi Chiang ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cellular immunity; Hepatitis B virus; Humoral immunity; IgG subclass; Immunopathology; Regulatory T cell

Indexed keywords

ALPHA INTERFERON; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN G; INTERLEUKIN 2; RIBAVIRIN;

ADAPTIVE IMMUNITY; CELLULAR IMMUNITY; HEPATITIS B; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; IMMUNOPATHOLOGY; INNATE IMMUNITY; LIVER DISEASE; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; REVIEW; VIRUS CLASSIFICATION; VIRUS MORPHOLOGY; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY; LIVER; VIRUS ATTACHMENT;

EID: 57449093624     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.1080/08830180802295757     Document Type: Review

References (106)

1. B. Rehermann and M. Nascimbeni, Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5: 215-229, 2005.
2. M. Gambarin-Gelwan, Hepatitis B in pregnancy. Clin Liver Dis 11: 945-963, 2007.
3. S. Martin-Vilchez P. Sanz-Cameno Y. Rodriguez-Munoz P.L. Majano, F. Molina-Jimenez M. Lopez-Cabrera R. Moreno-Otero, and E. Lara-Pezzi, The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells. Hepatology 47: 1872-1883, 2008.
4. M. Nassal and H. Schaller, Hepatitis B virus replication - an update. J Viral Hepat 3: 217-226, 1996.
5. C.Y. Lu, Y.H. Ni, B.L. Chiang, P.J. Chen, M.H. Chang, L.Y. Chang, I.J. Su, H.S. Kuo, L.M. Huang, D.S. Chen, and C.Y. Lee, Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. J Infect Dis 197: 1419-1426, 2008.
6. D. Ganem and A.M. Prince, Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 350: 1118-1129, 2004.
7. C.E. Stevens, R.P. Beasley, J. Tsui, and W.C. Lee, Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 292: 771-774, 1975.
8. V. Bruss, Envelopment of the hepatitis B virus nucleocapsid. Virus Res 106: 199-209, 2004.
9. J. Summers, A. O'Connell, and I. Millman, Genome of hepatitis B virus: restriction enzyme cleavage and structure of DNA extracted from Dane particles. Proc Natl Acad Sci USA 72: 4597-4601, 1975.
10. C.F. Huang, S.S. Lin, Y.C. Ho, F.L. Chen, and C.C. Yang, The immune response induced by hepatitis B virus principal antigens. Cell Mol Immunol 3: 97-106, 2006.
11. D. Ganem, Assembly of hepadnaviral virions and subviral particles. Curr Top Microbiol Immunol 168: 61-83, 1991.
12. U. Klingmuller and H. Schaller, Hepadnavirus infection requires interaction between the viral pre-S domain and a specific hepatocellular receptor. J Virol 67: 7414-7422, 1993.
13. D. Ganem Virology, The X files - one step closer to closure. Science 294: 2299-2300, 2001.
14. M. Nassal, Hepatitis B viruses: reverse transcription a different way. Virus Res, 134: 235-249, 2008.
15. L.G. Guidotti and F.V. Chisari, Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol 1: 23-61, 2006.
16. S. Pungpapong, W.R. Kim, and J.J. Poterucha, Natural history of hepatitis B virus infection: an update for clinicians. Mayo Clin Proc 82: 967-975, 2007.
17. M.J. Kim, O.S. Kwon, N.S. Chung, S.Y. Lee, H.S. Jung, D.K. Park, Y.S. Ku, Y.K. Kim, Y.S. Kim, and J.H. Kim, The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis. Korean J Hepatol 14: 67-76, 2008.
18. D.Y. But, C.L. Lai, and M.F. Yuen, Natural history of hepatitis-related hepatocellular carcinoma. World J Gastroenterol 14: 1652-1656, 2008.
19. D.I. Hoar, T. Bowen, D. Matheson, and M.C. Poon, Hepatitis B virus DNA is enriched in polymorphonuclear leukocytes. Blood 66: 1251-1253, 1985.
20. L.M. Fawaz, E. Sharif-Askari, and J. Menezes, Up-regulation of NK cytotoxic activity via IL-15 induction by different viruses: a comparative study. J Immunol 163: 4473-4480, 1999.
21. C.A. Biron, K.B. Nguyen, G.C. Pien, L.P. Cousens, and T.P. Salazar-Mather, Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17: 189-220, 1999.
22. T. Ranson, C.A. Vosshenrich, E. Corcuff, O. Richard, W. Muller, and J.P. Di-Santo, IL-15 is an essential mediator of peripheral NK-cell homeostasis. Blood 101: 4887-4893, 2003.
23. C. de Lalla, N. Festuccia, I. Albrecht, H. D. Chang, G. Andolfi, U. Benninghoff, F. Bombelli, G. Borsellino, A. Aiuti, A. Radbruch, P. Dellabona, and G. Casorati. Innate-like effector differentiation of human invariant NKT cells driven by IL-7. J Immunol 180: 4415-4424, 2008.
24. V.V. Parekh, S. Lalani, and L.K. Van, The in vivo response of invariant natural killer T cells to glycolipid antigens. Int Rev Immunol 26: 31-48, 2007.
25. T. Ranson, C.A. Vosshenrich, E. Corcuff, O. Richard, V. Laloux, A. Lehuen, and J.P. Di Santo, IL-15 availability conditions homeostasis of peripheral natural killer T cells. Proc Natl Acad Sci USA 100: 2663-2668, 2003.
26. G. Sitia, M. Isogawa, M. Iannacone, I.L. Campbell, F.V. Chisari, and L.G. Guidotti, MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs. J Clin Invest 113: 1158-1167, 2004.
27. K. Ando, L.G. Guidotti, S. Wirth, T. Ishikawa, G. Missale, T. Moriyama, R.D. Schreiber, H.J. Schlicht, S.N. Huang, and F.V. Chisari, Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J Immunol 152: 3245-3253, 1994.
28. L.V. Tsui, L.G. Guidotti, T. Ishikawa, and F.V. Chisari, Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes. Proc Natl Acad Sci USA 92: 12398-12402, 1995.
29. Y. Chen, H. Wei, B. Gao, Z. Hu, S. Zheng, and Z. Tian, Activation and function of hepatic NK cells in hepatitis B infection: an underinvestigated innate immune response. J Viral Hepat 12: 38-45, 2005.
30. C. de Lalla, G. Galli, L. Aldrighetti, R. Romeo, M. Mariani, A. Monno, S. Nuti, M. Colombo, F. Callea, S.A. Porcelli, P. Panina-Bordignon, S. Abrignani, G. Casorati, and P. Dellabona, Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis. J Immunol 173: 1417-1425, 2004.
31. B. Fischler, J. Nystrom, T. Bjornsdottir, G. Lindh, and C. Hultgren, Virus-specific T cell immune response in children and adolescents with chronic hepatitis B virus infection. J Pediatr Gastroenterol Nutr 45: 75-83, 2007.
32. T.I. Michalak, P.D. Hodgson, and N.D. Churchill, Posttranscriptional inhibition of class I major histocompatibility complex presentation on hepatocytes and lymphoid cells in chronic woodchuck hepatitis virus infection. J Virol 74: 4483-4494, 2000.
33. L.G. Guidotti and F.V. Chisari, To kill or to cure: options in host defense against viral infection. Curr Opin Immunol 8: 478-483, 1996.
34. M.F. Yuen, D.K. Wong, B.J. Zheng, C.C. Chan, J.C. Yuen, B.C. Wong, and C.L. Lai, Difference in T helper responses during hepatitis flares in hepatitis B e antigen (HBeAg)-positive patients with genotypes B and C: implication for early HBeAg seroconversion. J Viral Hepat 14: 269-275, 2007.
35. K. Ma, W. Xu, X. Shao Yanyue, L. Hu, H. Xu, Z. Yuan, X. Zheng, and S. Xiong, Coimmunization with RANTES plasmid polarized Th1 immune response against hepatitis B virus envelope via recruitment of dendritic cells. Antiviral Res 76: 140-149, 2007.
36. H. Cooksley, S. Chokshi, Y. Maayan, H. Wedemeyer, P. Andreone, R. Gilson, T. Warnes, S. Paganin, F. Zoulim, D. Frederick, A.U. Neumann, C.L. Brosgart, and N.V. Naoumov, Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+ T-cell reactivity. Antimicrob Agents Chemother 52: 312-320, 2008.
37. J. Li, J. Wang, K. Tian, Y. Wang, L. Zhang, and H. Huang, Epidemiology of hepatitis B, C, D and G viruses and cytokine levels among intravenous drug users. J. Huazhong Univ Sci Technol Med Sci 26: 221-224, 2006.
38. T. Forsthuber, H.C. Yip, and P.V. Lehmann, Induction of TH1 and TH2 immunity in neonatal mice. Science 271: 1728-1730, 1996.
39. C. Barrios, P. Brawand, M. Berney, C. Brandt, P.H. Lambert, and C.A. Siegrist, Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting. Eur J Immunol 26: 1489-1496, 1996.
40. T.R. Mosmann, H. Cherwinski, M.W. Bond, M.A. Giedlin, and R.L. Coffman, Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136: 2348-2357, 1986.
41. S.R. Paludan, Interleukin-4 and interferon-gamma: the quintessence of a mutual antagonistic relationship. Scand J Immunol 48: 459-468, 1998.
42. A. Billiau, Interferon-gamma: biology and role in pathogenesis. Adv Immunol 62: 61-130, 1996.
43. T.R. Mosmann, and S. Sad, The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17: 138-146, 1996.
44. R.A. Seder, and W.E. Paul, Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol 12: 635-673, 1994.
45. S.H. Kim, S.H. Kim, H.K. Oh, C.J. Ryu, S.Y. Park, and H.J. Hong, In vivo hepatitis B virus-neutralizing activity of an anti-HBsAg humanized antibody in chimpanzees. Exp Mol Med 40: 145-149, 2008.
46. D.R. Burton, R.A. Williamson, and P.W. Parren, Antibody and virus: binding and neutralization. Virology 270: 1-3, 2000.
47. K. Kakimi, T.E. Lane, S. Wieland, V.C. Asensio, I.L. Campbell, F.V. Chisari, and L.G. Guidotti, Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. J Exp Med 194: 1755-1766, 2001.
48. K. Falasca, C. Ucciferri, M. Dalessandro, P. Zingariello, P. Mancino, C. Petrarca, E. Pizzigallo, P. Conti, and J. Vecchiet, Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. Ann Clin Lab Sci 36: 144-150, 2006.
49. R.A. Heijtink, H.L. Janssen, W.C. Hop, A.D. Osterhaus, and S.W. Schalm, Interferon-alpha therapy for chronic hepatitis B: early response related to pretreatment changes in viral replication. J Med Virol 63: 217-219, 2001.
50. F. Marotta, B. Vangieri, A. Cecere, and A. Gattoni, The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect. Clin Ter 155: 187-199, 2004.
51. F.V. Chisari and C. Ferrari, Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13: 29-60, 1995.
52. T.H. Tsai, C.F. Huang, J.C. Wei, M.S. Ho, L. Wang, W.Y. Tsai, C.C. Lin, F.L. Xu, and C.C. Yang, Study of IgG subclass profiles of anti-HBs in populations with different HBV infection status. Viral Immunol 19: 277-284, 2006.
53. Y.Y. Yang, C.F. Huang, J.C. Wei, M.S. Ho, L.N. Wang, S.J. Lin, W.Y. Tsai, C.C. Lin, F. Xu, and C.C. Yang, The study of IgG subclass profiles of anti-hbc in populations with different status of HBV infection. Cell Mol Immunol 2: 393-408, 2005.
54. L. Wang, S.J. Lin, J.H. Tsai, C.H. Tsai, C.C. Tsai, and C.C. Yang, Anti-hepatitis B surface antigen IgG1 subclass is predominant in individuals who have recovered from hepatitis B virus infection, chronic carriers, and vaccines. Med Microbiol Immunol 194: 33-38 , 2005.
55. J.H. Hoofnagle, Serologic markers of hepatitis B virus infection. Annu Rev Med 32: 1-11, 1981.
56. R.M. Borzi, P. Dal Monte, M.C. Honorati, and A. Facchini, IgG subclass distribution of anti-HBs antibodies following vaccination with cDNA HBsAg. J Immunol Methods 146: 17-23, 1992.
57. R.M. Zinkernagel, Immunology taught by viruses, Science 271: 173-178, 1996.
58. P. Carotenuto, I. Quinti, O. Pontesilli, A.J. Hall, G.G. DeLange, H.C. Whittle, R. D'Amelio, and F. Aiuti, Response to hepatitis B vaccine in a cohort of Gambian children. Pediatr Infect Dis J 14: 215-220, 1995.
59. A. Morell, B. Roth-Wicky, and F. Skvaril, Immunoglobulin G subclass restriction of antibodies against hepatitis B surface antigen. Infect Immun 39: 565-568, 1983.
60. C.C. Yang, C.C. Lin, L. Wang, C.S. Ku, and C.K. Chen, Anti-HBc IgG subclasses in different populations by comparing a variety of ELISA plates. J Immunoassay Immunochem 22: 33-45, 2001.
61. L. Wang, T.H. Tsai, C.F. Huang, M.S. Ho, D.B. Lin, Y.C. Ho, S.S. Lin, J.C. Wei, M.C. Chou, and C.C. Yang, Utilizing self-prepared ELISA plates for a cross-population study of different anti-HBe IgG subclass profiles. J Med Virol 79: 495-502, 2007.
62. K. Townsend, M. Sallberg, J. O'Dea, T. Banks, D. Driver, S. Sauter, S.M. Chang, D.J. Jolly, S.J. Mento, D.R. Milich, and W.T. Lee, Characterization of CD8+ cytotoxic T-lymphocyte responses after genetic immunization with retrovirus vectors expressing different forms of the hepatitis B virus core and e antigens. J Virol 71: 3365-3374, 1997.
63. G. Torgano, M. Vecchi, M. Podda, M. Zuin, E. Arosio, P.M. Battezzati, and R. de Franchis, Primary biliary cirrhosis is associated with specific changes in liver IgG-bearing cell subpopulations. J Hepatol 22: 545-550, 1995.
64. S.M. Akbar, N. Horiike, M. Onji, and Y. Ohta, Immunoglobulin G subclasses of antibodies to hepatitis B core antigen in HBs antigen positive liver diseases. J Gastroenterol Hepatol 6: 71-76, 1991.
65. M. Sallberg, H. Norder, and L.O. Magnius, Comparison of class and subclass distribution of antibodies to the hepatitis B core and B e antigens in chronic hepatitis B. J Med Virol 30: 1-6, 1990.
66. F. Skvaril and H. Joller-Jemelka, IgG subclasses of anti-HBs antibodies in vaccinated and nonvaccinated individuals and in anti-HBs immunoglobulin preparations. Int Arch Allergy Appl Immunol 73: 330-337, 1984.
67. H. Gregorek, K. Madalinski, M. Woynarowski, J. Mikolajewicz, M. Syczewska, and J. Socha, IgG subclass distribution of hepatitis B surface antigen antibodies induced in children with chronic hepatitis B infection after interferon-α therapy. J Infect Dis 181: 2059-2062, 2000.
68. H. Gregorek, K. Dzieranowska-Fangrat, M. Woynarowski, P. Jówiak, E. Witkowska-Vogtt, J. Socha, M. Syczewska, and K. Madaliñski, Persistence of HBV-DNA in children with chronic hepatitis B who seroconverted to anti-HBs antibodies after interferon-α therapy: correlation with specific IgG subclass responses to HBsAg. J Hepatol 42: 486-490, 2005.
69. A.M. van Loon, F.W. Heessen, and J.T. van der Logt, Antibody isotype response after human cytomegalovirus infection. J Virol Methods 15: 101-107, 1987.
70. S.E. Carricart, D. Bustos, P. Biganzoli, S.E. Nates, and J. V. Pavan, Isotype immune response of IgG antibodies at the persistence and reactivation stages of human herpes virus 6 infection. J Clin Virol 31: 266-269, 2004.
71. S. Jenison, T. Yamada, C. Morris, B. Anderson, N. Torrez-Martinez, N. Keller, and B. Hjelle, Characterization of human antibody responses to four corners hantavirus infections among patients with hantavirus pulmonary syndrome. J Virol 68: 3000-3006, 1994.
72. A. Lundkvist, S. Bjorsten, and B. Niklasson, Immunoglobulin G subclass responses against the structural components of Puumala virus. J Clin Microbiol 31: 368-372, 1993.
73. J. Khalife, B. Guy, M. Capron, M.P. Kieny, J.C. Ameisen, L. Montagnier, J.P. Lecocq, and A. Capron, Isotypic restriction of the antibody response to human immunodeficiency virus. AIDS Res Hum Retroviruses 4: 3-9, 1988.
74. A. Linde, V.A. Sundqvist, T. Mathiesen, and B.Wahren, IgG subclasses to subviral components. Monogr Allergy 23: 27-32, 1988.
75. D.K. Wagner, D.L. Nelson, E.E. Walsh, C.B. Reimer, F.W. Henderson, and B.R. Murphy, Differential immunoglobulin G subclass antibody titers to respiratory syncytial virus F and G glycoproteins in adults. J Clin Microbiol 25: 748-750, 1987.
76. R.C. Aalberse, R. van der Gaag, and J. van Leeuwen, Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J Immunol 130: 722-726, 1983.
77. V.A. Sundqvist, A. Linde, and B. Wahren, Virus-specific immunoglobulin G subclasses in herpes simplex and varicella-zoster virus infections. J Clin Microbiol 20: 94-98, 1984.
78. Y.S. Hsu, R.N. Chien, C.T. Yeh, I.S. Sheen, H.Y. Chiou, C.M. Chu, and Y.F. Liaw, Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 35: 1522-1527, 2002.
79. P. Grigorescu-Sido, L. Calin, R. Manasia, S. Mirestean, V. Cret, C. Skorka, and A. Grigorescu-Sido, Results of interferon treatment in children with chronic hepatitis B. Rom J Gastroenterol 11: 285-290, 2002.
80. H. Bozkaya, M. Bozdayi, R. Turkyilmaz, M. Sarioglu, H. Cetinkaya, K. Cinar, K. Kose, C. Yurdaydin, and O. Uzunalimoglu, Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease. Hepatogastroenterology 47: 1675-1679, 2000.
81. C. Hultgren, D.R. Milich, O. Weiland, and M. Sallberg, The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses. J Gen Virol 79( Pt 10): 2381-2391, 1998.
82. M.A. Rico, J.A. Quiroga, D. Subira, S. Castanon, J.M. Esteban, M. Pardo, and V. Carreno, Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha. Hepatology 33: 295-300, 2001.
83. D.R. Milich, M.K. Chen, J.L. Hughes, and J.E. Jones, The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. J Immunol 160: 2013-2021, 1998.
84. D.R. Milich, F. Schodel, D.L. Peterson, J.E. Jones, and J.L. Hughes, Characterization of self-reactive T cells that evade tolerance in hepatitis B e antigen transgenic mice. Eur J Immunol 25: 1663-1672, 1995.
85. D.R. Milich, J. Jones, J. Hughes, and T. Maruyama, Role of T-cell tolerance in the persistence of hepatitis B virus infection. J Immunother Emphasis Tumor Immunol 14: 226-233, 1993.
86. P. Vanlandschoot, T. Cao, and G. Leroux-Roels, The nucleocapsid of the hepatitis B virus: a remarkable immunogenic structure. Antiviral Res 60: 67-74, 2003.
87. S.T. Ishizaka, P. Piacente, J. Silva, and E.M. Mishkin, IgG subtype is correlated with efficiency of passive protection and effector function of anti-herpes simplex virus glycoprotein D monoclonal antibodies. J Infect Dis 172: 1108-1111, 1995.
88. D.H. Lynch, F. Ramsdell, and M.R. Alderson, Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 16: 569-574, 1995.
89. X. Chen, M. Li, X. Le, W. Ma, and B. Zhou, Recombinant hepatitis B core antigen carrying preS1 epitopes induce immune response against chronic HBV infection. Vaccine 22: 439-446, 2004.
90. X.S. He, H.S. Chen, K. Chu, M. Rivkina, and W.S. Robinson, Costimulatory protein B7-1 enhances the cytotoxic T cell response and antibody response to hepatitis B surface antigen. Proc Natl Acad Sci USA 93: 7274-7278, 1996.
91. S. Beckebaum, V.R. Cicinnati, and G. Gerken, DNA-based immunotherapy: potential for treatment of chronic viral hepatitis? Rev Med Virol 12: 297-319, 2002.
92. C.X. Wang, J.F. Wang, M. Liu, X. Zou, X.P. Yu, X.J. Yang, and G.X. Zheng, Expression of HLA class I and II on peripheral blood lymphocytes in HBV infection. Chin Med J (Engl) 119: 753-756, 2006.
93. S.I. Khakoo, R. Ling, I. Scott, A.I. Dodi, T.J. Harrison, G.M. Dusheiko, and J.A. Madrigal, Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg, anti-HBe positive individuals. Gut 47: 137-143, 2000.
94. C. Boni, A. Penna, G.S. Ogg, A. Bertoletti, M. Pilli, C. Cavallo, A. Cavalli, S. Urbani, R. Boehme, R. Panebianco, F. Fiaccadori, and C. Ferrari, Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology 33: 963-971, 2001.
95. B.J. Zheng, J. Zhou, D. Qu, K.L. Siu, T.W. Lam, H.Y. Lo, S.S. Lee, and Y.M.Wen, Selective functional deficit in dendritic cell-T cell interaction is a crucial mechanism in chronic hepatitis B virus infection. J Viral Hepat 11: 217-224, 2004.
96. J.W. Yewdell and J.R. Bennink, Mechanisms of viral interference with MHC class I antigen processing and presentation, Annu Rev Cell Dev Biol 15: 579-606, 1999.
97. M.R. Brunetto, M.M. Giarin, F. Oliveri, E. Chiaberge, M. Baldi, A. Alfarano, A. Serra, G. Saracco, G. Verme, H.Will, and F Bonino, Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proc Natl Acad Sci USA 88: 4186-4190, 1991.
98. J.N. Stoop, R.G. van der Molen, E.J. Kuipers, J.G. Kusters, and H.L. Janssen, Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B. Virology 361: 141-148, 2007.
99. G. Yang, A. Liu, Q. Xie, T.B. Guo, B. Wan, B. Zhou, and J.Z. Zhang, Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B. Int Immunol 19: 133-140, 2007.
100. T. Manigold and V. Racanelli, T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies. Lancet Infect Dis 7: 804-813, 2007.
101. C. Baecher-Allan and D. A. Hafler. Suppressor T cells in human diseases. J Exp Med 200: 273-276, 2004.
102. H. Jonuleit, E. Schmitt, H. Kakirman, M. Stassen, J. Knop, and A. H. Enk, Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J Exp Med 196: 255-260, 2002.
103. J.L. Fu, D.P. Xu, P. Zhao, L.M. Chen, H. Zhang, C.B. Zhou, J.X. Yao, Y.H. Rong, and F.S. Wang, The characterization of regulatory T cells in peripheral blood of HBV-infected patients. Zhonghua Yi Xue Za Zhi 86: 1522-1525, 2006.
104. D. Xu, J. Fu, L. Jin, H. Zhang, C. Zhou, Z. Zou, J.M. Zhao, B. Zhang, M. Shi, X. Ding, Z. Tang, Y.X. Fu, and F.S.Wang, Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 177: 739-747, 2006.
105. Y. Kondo, K. Kobayashi, Y. Ueno, M. Shiina, H. Niitsuma, N. Kanno, T. Kobayashi, and T. Shimosegawa, Mechanism of T cell hyporesponsiveness to HBcAg is associated with regulatory T cells in chronic hepatitis B. World J Gastroenterol 12: 4310-4317, 2006.
106. J.A. Chichester, M.A. Feitelson, and C.E. Calkins, Transient inhibition of Th1-type cytokine production by CD4 T cells in hepatitis B core antigen immunized mice is mediated by regulatory T cells, Immunology 118: 438-448, 2006.